Chemotherapy (undisclosed regimen)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Chemotherapy (undisclosed regimen), covering 2013-07-16 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]